B.P. Marsh & Partners PLC
08 July 2026
B.P. Marsh & Partners Plc
("B.P. Marsh" or the "Company")
PDMR and Director Dealings
B.P. Marsh (AIM: BPM), the specialist investor in early-stage financial services businesses, announces that it has been notified that Mr. Dan Topping, Chief Executive Officer has purchased an aggregate of 2,890 ordinary shares of 10 pence each in the Company ("Ordinary Shares").
The Company has been notified that on 6 July 2026, Mr. Topping purchased 2,890 ordinary shares at 692p per share, for a total of £19,998.80.
Following this transaction, Mr. Topping holds a beneficial interest in:
· 155,677 Ordinary Shares (including 14,594 shares held by persons closely associated with him)
· 18,751 Ordinary Shares held through the Company's SIP Trust, and
· 123,715 Ordinary Shares under the Company's Joint Share Ownership Plan.
In total, Mr. Topping's new total represents approximately 0.83% of the Company's voting rights.
Mr. Topping also has options over 310,000 Ordinary Shares as part of the Company's Share Option Plan announced on 20 November 2023.
The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||
|
a) |
Name |
Daniel Topping |
||
|
2 |
Reason for notification |
|||
|
a) |
Position / status |
Chief Executive Officer, PDMR |
||
|
b) |
Initial notification / amendment |
Initial |
||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||
|
a) |
Name |
B.P. Marsh & Partners Plc |
||
|
b) |
LEI |
2138008G8EPE3HAHEM13 |
||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
|
a) |
Description of the financial instrument, type of instrument |
Ordinary shares of 10 pence each |
||
|
Identification code |
ISIN: GB00B0XLRJ79 |
|||
|
b) |
Nature of the transaction |
Purchase of Ordinary Shares via SIPP |
||
|
c) |
Price(s) and volumes(s) |
|
||
|
d) |
Aggregated information |
N/A |
||
|
e) |
Date of the transaction |
2026-07-06 |
||
|
f) |
Place of the transaction |
London Stock Exchange, AIM (XLON) |
||
For further information on B.P. Marsh, its strategy and current portfolio, please contact:
|
B.P. Marsh & Partners Plc Daniel Topping / Alice Foulk |
+44 (0)20 7233 3112 |
|
Nominated Adviser & Joint Corporate Broker: Singer Capital Markets Advisory LLP Charles Leigh-Pemberton / Peter Steel / James Todd
|
+44 (0)20 7496 3000 |
|
Joint Corporate Broker: Investec Bank plc Christopher Baird / Maria Gomez de Olea/ Gordon Hamilton
|
+44 (0)20 7597 5970 |
|
Financial PR & Investor Relations: Tavistock Simon Hudson / Katie Hopkins / Kuba Stawiski |
+44 (0)20 7920 3150 |
About B.P. Marsh
B.P. Marsh & Partners Plc (AIM: BPM) is a specialist investor in early stage and small to medium-sized financial services intermediary businesses, with a particular focus on the insurance sector. Bridging the gap to traditional private equity funding rounds, B.P. Marsh takes a typical initial equity stake of up to £5m, often complemented by loans, and is able to tailor its investment model to each opportunity. Taking a long-term view of its investments, with an average holding period of around seven years, the Group supplies strategic insight and capital while empowering entrepreneurial management teams to grow their businesses.
The B.P. Marsh portfolio is diversified by geography and class of business, spanning insurance brokers, underwriting agencies and financial advisers in the UK, Europe, North America and other international markets. For further information, including details of the current portfolio and recent exits, please visit: www.bpmarsh.co.uk.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.